Bad Bugs, ‘New’ Drugs: Updates on Antibiotic Treatment Options for Multidrug Resistant Gram-Negative Bacterial Infections Webcast

Bad Bugs, ‘New’ Drugs: Updates on Antibiotic Treatment Options for Multidrug Resistant Gram-Negative Bacterial Infections is organized by AchieveCE.

Release Date: 04/07/2025
Expiration Date: 04/07/2028

Description:
Antibiotic-resistant bacteria are a major problem both nationally and globally. Novel antibiotic options are being developed for treatment of multidrug resistant Gramnegative bacterial infections. This activity is intended to make pharmacists, pharmacy technicians, and nurses aware of these novel antibiotics to recognize their potential clinical utility, pharmacology, adverse effects, and clinical pearls as well as evaluate available literature on their use for treatment of such infections.

What you will learn:
Pharmacist Learning Objectives:
At the conclusion of this continuing education activity, the participant will be able to:

• Review common resistance mechanisms among Gram-negative bacteria
• Describe novel antibiotic agents based on their pharmacological properties and spectrum of activity
• Evaluate the role of novel antibiotic agents in the treatment of multidrug resistant Gram-negative bacterial infections based on emerging clinical data

Nurse / Pharmacy Technician Learning Objectives:
At the conclusion of this continuing education activity, the participant will be able to:

• Review common resistance mechanisms among Gram-negative bacteria
• List novel antibiotic agents based on their pharmacological properties and spectrum of activity
• Review literature on how novel antibiotic agents affects multidrug resistant Gram negative bacterial infections